MIT researchers have developed a groundbreaking method for gene editing that significantly reduces errors, making gene therapy safer and more effective for treating genetic diseases. This innovative approach promises a future of precise genomic alterations with fewer side effects.
In an unprecedented medical achievement, a child with a rare genetic disorder receives a customized CRISPR gene therapy, paving the way for future treatments of similar conditions.